Horizon Pharma CEO: Not A Mini-Valeant | Mad Money | CNBC



Its stock has been crushed lately thanks to Valeant comparisons. After its latest earnings, does the market have it all wrong? » Subscribe to CNBC: …

source CNBC

Related posts

Leave a Comment